The vast majority of pituitary tumors are benign, and less than 1% of pituitary tumors are malignant called pituitary adenocarcinomas.
The majority of pituitary tumors are benign and can be classified as prolactin cell adenomas, growth hormone cell adenomas, thyrotropin cell adenomas, adrenocorticotropin cell adenomas, gonadotropin adenomas, pleomorphic cell adenomas, and anaplastic cell adenomas, and are considered to be minimally invasive or craniotomies, as well as pharmacological treatments when detected.
Some pituitary tumors grow aggressively and tend to recur after surgery, but they are still more likely to be benign tumors in terms of their biological behavior. However, a few pituitary tumors, in addition to invasive growth, may have metastases to the brain, liver, bone marrow, or even the entire body, and are called pituitary adenocarcinomas, which are malignant tumors. Malignant tumors of the pituitary gland need to be treated with surgery as soon as possible and further treatment such as radiotherapy after surgery.
It is recommended that patients with pituitary tumors should seek medical treatment in time and under the guidance of doctors, so as to avoid delaying the condition.